coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Shoreham And Southwick PCN, Adur · Health Inequalities Profile

    PCN U37037 · NHS Surrey and Sussex Integrated Care Board; NHS Sussex Integrated Care Board · 1 GP practice

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    36,093

    Registered population

    56.5% aged 18–64

    23.7%

    Aged 65+

    ICB 21.9% · England 17.9%

    7.2%

    Ethnic minority (non-White)

    2.2% Asian · England 9.6%

    0.0%

    In IMD quintile 1

    ICB 9.2% · England 21.0%

    0

    Core20 residents (est.)

    Resident basis; registered basis 0 · see page 3

    6,359

    Hypertension register

    +2.83% in 3 yrs · England +5.60%

    363

    SMI register

    53.9% of Adur's

    712

    COPD register

    Reviews -10.92% in 3 yrs

    Forecast to 2030

    6,761

    Hypertension patients, 2030

    +402 on today

    67.6%

    QRISK ≥20% on statins, 2030

    +4.04pp over 3 yrs

    6.6%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    66.3%
    Hypertension control and lipid therapy lag England.

    Despite 91.3% BP monitoring, hypertension control fell 4.5 pp to 66.3% (England 70.3%) and high-risk lipid therapy is 58.6% (England 63.6%).

    57.5%
    Respiratory and SMI annual reviews trail benchmarks.

    Asthma reviews reach 57.5% (1,092 unreviewed; England 65.7%), COPD reviews 68.8% (England 76.4%) and SMI BMI checks 74.6% (England 82.1%).

    83.0%
    Screening and age-five MMR1 uptake exceed England.

    Breast screening is 83.0% (England 69.9%), cervical screening aged 25-49 is 73.5% (England 66.8%) and age-5 MMR1 reaches 98.9% (England 91.7%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    With 23.7% aged 65+, an older demographic may shape chronic care needs

    Shoreham and Southwick PCN serves 36,093 registered patients across a single practice, Adur Health Partnership. Patients aged 65+ comprise 23.7% (8,542) of the list, exceeding Adur (23.3%), NHS Sussex Integrated Care Board (21.9%) and England (17.9%). Those aged 18–64 represent 56.5% (20,398; Adur 58.0%, ICB 60.5%, England 62.7%), and aged 0–17 represent 19.8% (7,153; Adur 18.7%, ICB 17.7%, England 19.6%). Census resident data (not registered patients) shows 92.8% White (Adur 93.4%, ICB 91.0%, England 81.1%), with 7.2% non-White. Projected 2030 list growth is 0.5% (method unverified; Adur 0.7%, ICB 2.1%, England 2.3%).

    Age profile

    0–1719.8%
    18–6456.5%
    65+23.7%

    65+: ICB 21.9%, England 17.9%

    Ethnicity

    White92.8%
    Mixed2.8%
    Asian2.2%
    Other1.4%
    Black0.8%

    Older people · falls rows are Adur local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Adur LA)2,1742,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)78.4%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)58.4%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Adur LA)1,1479819552024/25
    Falls deaths, all ages, per 100,000 (Adur LA)14.314.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Average IMD decile is 7.0 with 0.0% in Core20 despite substantial clinical caseloads

    The PCN records an average IMD decile of 7.0, above Adur (6.6), NHS Sussex Integrated Care Board (6.1) and England (5.5), with 0.0% of registered patients in Core20 (England 21.0%), zero estimated Core20 residents and zero associated LSOAs in deciles 1 or 2. However, the PCN manages 363 severe mental illness patients (53.9% of Adur's register), where physical health checks lag England: BMI recording is 74.6% (England 82.1%) and alcohol recording is 71.0% (England 81.8%). With zero Core20 areas, tackling health inequalities relies on targeting clinical registers rather than geographic.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Adur Health0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    363

    SMI register

    1.00% recorded prevalence

    141

    Learning disability register

    0.39% recorded prevalence

    11

    Care homes, 357 beds

    In the PCN catchment

    9.4%

    Provide unpaid care

    Adur, Census 2021

    The PCN records 363 severe mental illness patients (1.0%; Adur 1.0%, ICB 1.1%, England 1.0%) and 141 learning disability patients (0.4%; Adur 0.5%, ICB 0.6%, England 0.6%). Catchment facilities include 11 care homes with 357 beds, alongside borough-level Adur context of 9.4% unpaid carers. Recorded learning disability prevalence sits below comparators, though crude prevalence does not establish unmet need or under-detection.

    Severe mental illness: physical health checks

    For patients on the severe mental illness register, BMI recording fell 5.4 pp over 2023 to 2025 to 74.6% (England 82.1%, +5.1 pp), while blood pressure check coverage is 77.6% (England 83.4%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,359

    Hypertension register

    +2.83%

    Register growth, 3 yrs

    Adur +5.74% · England +5.60%

    −0.89pp

    BP control, under 80

    ≤140/90 · +1.44pp aged 80+

    +402

    More patients by 2030

    Forecast 6,761 (18.54%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 17.5% (6,359 patients), above England (15.2%) and NHS Sussex ICB (16.3%), though below Adur (19.2%). Monitoring reach is strong, with 91.3% receiving a recent blood pressure check (England 90.0%). However, patients treated to target fell 4.5 pp (-6.3%) over 2023 to 2025 to 66.3%, trailing Adur (68.1%), the ICB (69.1%) and England (70.3%, +2.5 pp). Crude register figures are not age-adjusted. With blood pressure control falling below national benchmarks despite high testing rates, clinical review and medication titration appear to be key operational priorities.

    Lipids and statins

    Among patients with QRISK ≥ 20%, 58.6% receive lipid-lowering therapy, trailing Adur (61.1%), NHS Sussex ICB (60.0%) and England (63.6%). CKD lipid coverage is also lower at 66.1% (England 70.3%). Fewer at-risk cardiovascular patients receive lipid-lowering therapy than national rates imply, highlighting an immediate opportunity for systematic primary prevention recall.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202654,870£2.70£2.42£1.86£148,149
    Cardiovascular (all), 202577,941£3.60£3.32£3.33£280,588

    In 2026, the PCN prescribed 54,870 items for lipid-regulating drugs at £2.70 per item (Adur £3.54, NHS Sussex ICB £2.42, England £1.86), spending £46,091 more than at England's unit cost across 54,870 items. Review of formulary choices could help align unit costs without compromising treatment coverage.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −3.88%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +3.28%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 7.5% (2,570 patients; England 6.6%), but 12-month reviews fell 3.9% over 2023 to 2025 to 57.5% (England 65.7%, +4.4%), leaving about 1,100 unreviewed patients. COPD reviews fell 10.9% over 2023 to 2025 to 68.8% (England 76.4%, +2.8%) with 2.0% prevalence (712 patients). Recorded second-hand smoking status for ages 6–19 reached 88.4% (England 78.8%), while asthma prescribing for ages 5–19 was 1,195 per 1,000 (England 1,488). Falling review coverage across asthma and COPD could reflect recall capacity constraints, unverified locally.

    Cancer register and children's immunisation

    Cancer prevalence is 5.4% (1,969 patients; England 3.8%). In Q1 2025/26 childhood immunisations, 12-month 6-in-1 coverage is 97.0% and age-5 MMR dose 1 is 98.9%, both exceeding the 95.0% target. However, 24-month coverage sits below the 95.0% target by 8.4 pp for 6-in-1 (86.6%) and by 5.4 pp for MMR dose 1 (89.6%), while age-5 MMR dose 2 is 94.6% (4.3 pp below dose 1).

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months97.0%

    England 91.0%

    6-in-1 complete primary course at 24 months86.6%

    England 92.2%

    MMR dose 1 at 24 months89.6%

    England 88.3%

    MMR dose 2 at age 594.6%

    England 82.8%

    4-in-1 pre-school booster at age 594.6%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    58.5%

    Sussex ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,360

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Sussex ICBEnglandNo usable stageStaged cancers
    Prostate56.6%53.2%19%1,668
    Breast86.1%85.4%23%1,400
    Bowel49.8%47.0%26%1,133
    Lung30.3%33.8%15%1,058
    Skin cancer95.3%87.8%17%698

    PCN cancer prevalence is 5.4% (1,969 patients, +10.5% over 2023 to 2025; England +9.0%). Screening coverage exceeds England for breast (83.0% vs 69.9%) and cervical ages 25–49 (73.5% vs 66.8%), though cervical coverage fell 1.0% over 2023 to 2025 (England -1.0%). Across NHS Sussex ICB, 58.5% of cancers with a known stage were diagnosed at stage 1 or 2 in 2022 (4,799 of 8,209; England 55.3%), 16.5 pp below the 75.0% national ambition by 2028 (about 1,360 extra early-stage cases needed). Known stage was recorded for 64.3% of registrations (England 67.0%). Staging is published at ICB level only.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, University Hospitals Sussex NHS Foundation Trust achieved 65.2% on the 62-day referral to treatment standard, below the 85.0% standard by 19.8 pp (NHS Surrey and Sussex ICB 71.5%, England 71.2%, Surrey and Sussex Healthcare NHS Trust 70.0%, East Sussex Healthcare NHS Trust 67.0%). The trust reached 74.0% on the 28-day faster diagnosis standard (standard 75.0%; England 79.3%) and 76.8% for 31-day treatment (standard 96.0%; England 92.5%). Diagnostic tests waiting 6+ weeks reached 12.9% overall (England 23.1%), with 39.3% for colonoscopy and 45.4% for flexi sigmoidoscopy (England 30.8% and 32.1%).

    Pathways within standard (%)SussexEast Sussex HealthcareSurrey and Sussex HealthcareSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)74.0184.2077.7479.2979.32
    31-day treatment (96%)76.7998.1996.2090.4592.50
    62-day referral to treatment (85%)65.2067.0469.9771.5171.16
    Diagnostic waits over 6 weeks (%)SussexEast Sussex HealthcareSurrey and Sussex HealthcareEngland
    MRI5.626.4827.5321.40
    CT8.570.4818.499.92
    Echocardiography0.3921.9443.7828.48
    Colonoscopy39.350.7415.1130.83
    Gastroscopy20.020.3121.0629.02
    All 15 DM01 tests12.955.2728.5023.14
    Community services activityWest Sussex residentsSurrey and Sussex ICB
    Care contacts78,050309,615
    Referrals16,01566,930
    Patients with a contact19,77085,660

    Community services (residents of West Sussex), Jun 2026 (provisional). In June 2026 (provisional), West Sussex recorded 115,485 community care activities and 78,050 care contacts across 19,770 patients, alongside 16,015 referrals. Adults aged 65+ accounted for 72.7% of all contacts (56,740 of 78,050). Across NHS Surrey and Sussex ICB, 309,615 contacts were recorded for 85,660 patients. These experimental figures reflect submitting providers across local authority and ICB geographies rather than an exclusive PCN cohort.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Overall QOF reaches 98.1% while website contact ease trails England at 33.6%

    In 2025/26, Adur Health Partnership achieved 98.1% overall QOF points (England 92.5%) and 100.0% in the clinical domain (England 97.1%). Vaccination achievement reached 83.3% (England 55.2%). The personalised care adjustment rate across all domains was 10.0%, matching England (10.0%). Domain points measure recorded indicator achievement and are distinct from overall population reach.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Adur Health1890.049.3%71.3%78.7%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNAdurAssetPCNAdur
    Care homes (catchment)11 (357 beds)n/aSchools (catchment)23n/a
    Children's centres24Places of worship1929
    Libraries23Homelessness support (VCS)0no data
    Day centres (VCS)n/a1Carers support groups (VCS)n/a1
    Primary schools (LA maintained)45Primary academies57

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Hypertension and lipid escalation review

    Hypertension treated to target is 66.3% across 6,359 patients (Adur 68.1%, ICB 69.1%, England 70.3%), falling 4.5 pp over 2023 to 2025 (England +2.5 pp), while QRISK ≥ 20% lipid therapy is 58.6% (England 63.6%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    Respiratory annual review recall redesign

    Asthma 12-month review coverage is 57.5% across 2,570 patients (Adur 60.1%, ICB 62.5%, England 65.7%), falling 3.9% (England +4.4%) and leaving 1,092 unreviewed; COPD reviews fell 10.9% to 68.8% (712 patients, England 76.4%). Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    SMI checks and LD validation

    Across 363 SMI patients (53.9% of Adur's register), BMI checks fell 5.4 pp to 74.6% (England 82.1%, +5.1 pp) and alcohol fell 5.5 pp to 71.0% (England 81.8%); LD prevalence is 0.4% (141 patients, gap +56 to +71). Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older adult proactive care (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Inclusion health register outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI health check recall (p4)SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension titration review (p5)Hypertension patients treated to targetCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Childhood booster recall audit (p6)6-in-1 complete primary course at 24 months10YHP sickness to prevention · 95% targetPCN
    Cervical screening audit and recall (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Digital and telephony access overhaul (p9)GPPS easy to contact the practice using its website10YHP, hospital to communityPractice
    Option 1 · Hypertension and lipid escalation review (p12)Hypertension register · Hypertension patients treated to target · Hypertension patients treated to appropriate thresholdCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 2 · Respiratory annual review recall redesign (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · COPD registerCore20PLUS5 respiratoryPCN
    Option 3 · SMI checks and LD validation (p12)Severe mental illness register · SMI register with a BP check in the last 12 months · SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to Hope · 75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15